Learning Optimal Individualized Treatment Rules from Electronic Health Record Data
暂无分享,去创建一个
Ying Liu | Peng Wu | Chunhua Weng | Yuanjia Wang | Donglin Zeng | D. Zeng | Y. Liu | C. Weng | Yuanjia Wang | Peng Wu
[1] George Hripcsak,et al. Exploiting time in electronic health record correlations , 2011, J. Am. Medical Informatics Assoc..
[2] Stephen B. Johnson. Model Formulation: Generic Data Modeling for Clinical Rrepositories , 1996, J. Am. Medical Informatics Assoc..
[3] Paul Shekelle,et al. Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline From the American College of Physicians , 2012, Annals of Internal Medicine.
[4] S. Murphy,et al. Methodological Challenges in Constructing Effective Treatment Sequences for Chronic Psychiatric Disorders , 2007, Neuropsychopharmacology.
[5] James M. Robins,et al. Optimal Structural Nested Models for Optimal Sequential Decisions , 2004 .
[6] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[7] Rae Woong Park,et al. Characterizing treatment pathways at scale using the OHDSI network , 2016, Proceedings of the National Academy of Sciences.
[8] Nisa M. Maruthur,et al. Comparative Effectiveness and Safety of Medications for Type 2 Diabetes: An Update Including New Drugs and 2-Drug Combinations , 2011, Annals of Internal Medicine.
[9] G Hripcsak,et al. A Distribution-based Method for Assessing The Differences between Clinical Trial Target Populations and Patient Populations in Electronic Health Records , 2014, Applied Clinical Informatics.
[10] Russ B. Altman,et al. The utility of general purpose versus specialty clinical databases for research: Warfarin dose estimation from extracted clinical variables , 2010, J. Biomed. Informatics.
[11] Noémie Elhadad,et al. Identifying and mitigating biases in EHR laboratory tests , 2014, J. Biomed. Informatics.
[12] Donglin Zeng,et al. Estimating Individualized Treatment Rules Using Outcome Weighted Learning , 2012, Journal of the American Statistical Association.
[13] D. A. Freedman,et al. Adjusting for Nonignorable Drop-Out Using Semiparametric Nonresponse Models: Comment , 1999 .
[14] Corinna Cortes,et al. Support-Vector Networks , 1995, Machine Learning.
[15] G. Ginsburg,et al. The path to personalized medicine. , 2002, Current opinion in chemical biology.
[16] Ree Dawson,et al. Dynamic treatment regimes: practical design considerations , 2004, Clinical trials.
[17] Nicole A. Lazar,et al. Statistical Analysis With Missing Data , 2003, Technometrics.
[18] F. Collins,et al. A new initiative on precision medicine. , 2015, The New England journal of medicine.
[19] S. Murphy,et al. PERFORMANCE GUARANTEES FOR INDIVIDUALIZED TREATMENT RULES. , 2011, Annals of statistics.
[20] Joel H. Saltz,et al. Temporal Abstraction-based Clinical Phenotyping with Eureka! , 2013, AMIA.
[21] George Hripcsak,et al. Next-generation phenotyping of electronic health records , 2012, J. Am. Medical Informatics Assoc..
[22] Michael R. Kosorok,et al. Robust Hybrid Learning for Estimating Personalized Dynamic Treatment Regimens , 2016, 1611.02314.
[23] R. Little. SURVEY NONRESPONSE ADJUSTMENTS , 2002 .
[24] Donglin Zeng,et al. New Statistical Learning Methods for Estimating Optimal Dynamic Treatment Regimes , 2015, Journal of the American Statistical Association.
[25] Susan A Murphy,et al. Customizing treatment to the patient: adaptive treatment strategies. , 2007, Drug and alcohol dependence.